FBP1 knockdown decreases ovarian cancer formation and cisplatin resistance through EZH2-mediated H3K27me3

Worldwide, ovarian cancer (OC) is the seventh common cancer and the second most common cause of cancer death in women. Due to high rates of relapse, there is an urgent need for the identification of new targets for OC treatment. The far-upstream element binding protein 1 (FBP1) and enhancer of zeste...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiong, Xifeng, Lai, Xudong, Zhang, Jinli, Meng, Qingqi, Wang, Pengzhen, Qin, Shengnan, Liu, Wei, Wang, Yongxuan, Yao, Zhuo, Wang, Di, Li, Xiaojian, Liu, Zhihe, Miao, Haixiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2022
Materias:
Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469104/
https://www.ncbi.nlm.nih.gov/pubmed/36000567
http://dx.doi.org/10.1042/BSR20221002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9469104/
https://www.ncbi.nlm.nih.gov/pubmed/36000567
http://dx.doi.org/10.1042/BSR20221002

Ejemplares similares